| Literature DB >> 31436751 |
Takuya Okada1,2, Tomoyuki Odagaki1, Francisco López-Köstner3, Alejandro J Zárate3,4, Alejandra Ponce3, Udo Kronberg3, Stanko Karelovic5, Sergio Flores6, Ricardo Estela7, Takashi Ito1,8, Masamichi Yasuno1,2, Hiroyuki Uetake1,9, Kazuyuki Kojima10, Masanobu Kitagawa11.
Abstract
In Chile, the mortality from colorectal cancer has been on the rise. A national screening program based on a fecal immunochemical test was started in 2012 as an international collaboration with Japan. This case-control study was designed to identify the risk factors for colorectal cancer, with a goal of increasing the participation rate for colorectal cancer screening. In accordance with the Strengthening the Reporting of Observational Studies in Epidemiology guidelines, we conducted a case-control study from 2012 to 2017; 23 845 asymptomatic participants were enrolled in the study. Participants who were fecal immunochemical test-positive or had a family history of colorectal cancer underwent a colonoscopy. We analyzed the odds ratio of the risk factors for colorectal cancer, including sex, age, family history, BMI, hypertension, diabetes, regular use of nonsteroidal anti-inflammatory drugs, alcohol consumption, smoking, physical activity, and daily intake of certain food items. For the screening program, 202 cases of colorectal cancer were detected, and 195 of them were evaluated pathologically after resection. Of these, 173 cases (88.7%) had colorectal cancer stage 0/1, 151 (77.4%) of which were treated with endoscopic resection. In the multivariate analysis, male sex, family history of colorectal cancer, and low intake of cereals or fibers were closely related to a high colorectal cancer incidence. Moreover, participants in their 60s and 70s had a higher incidence of colorectal cancer than those in their 50s. These results suggest that intensive screening of the high-risk population can help in improving the detection of colorectal cancer, whereas higher consumption of cereals or fibers can be effective in preventing its onset.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31436751 DOI: 10.1097/CEJ.0000000000000531
Source DB: PubMed Journal: Eur J Cancer Prev ISSN: 0959-8278 Impact factor: 2.497